Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions

Journal of Ultrasound in Medicine

Volumn 27, Issue 6, 2008, Pages 821-831

  Du, Jing ^a   Li, Feng Hua ^a   Fang, Hua ^a   Xia, Jian Guo ^a   Zhu, Cai Xia ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast lesion; Contrast enhanced ultrasonography; Microvessel density; Vascular endothelial growth factor

Indexed keywords

BLOOD VESSELS; ENDOTHELIAL CELLS; ULTRASONOGRAPHY;

BREAST LESION; CONTRAST-ENHANCED ULTRASONOGRAPHY; IMMUNOHISTOCHEMICAL ANALYSIS; MICROVESSEL DENSITY; PERFUSION DEFECTS; QUANTITATIVE PARAMETERS; TIME-INTENSITY CURVES; VASCULAR ENDOTHELIAL GROWTH FACTOR;

MAMMOGRAPHY;

SONOVUE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; AREA UNDER THE CURVE; ARTICLE; BREAST LESION; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DENSITY; FEMALE; GRAY SCALE ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; MICROVESSEL DENSITY; PARAMETER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS;

EID: 46249109055     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2008.27.6.821     Document Type: Article

References (24)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30.
2. Broillet A, Hantson J, Ruegg C, Messager T, Schneider M. Assessment of microvascular perfusion changes in a rat breast tumor model using SonoVue to monitor the effects of different anti-angiogenic therapies. Acad Radiol 2005; 12(suppl 1):S28-S33.
3. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407:249-257.
4. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36: 169-180.
5. Heimann R, Ferguson D, Gray S, Hellman S. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res Treat 1998; 52:147-158.
6. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000; 5(suppl 1):37-44.
7. Wang Z, Tang J, An L, et al. Contrast-enhanced ultra-sonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med 2007; 26:757-762.
8. Ahlgren J, Risberg B, Villman K, Bergh J. Angiogenesis in invasive breast carcinoma: a prospective study of tumour heterogeneity. Eur J Cancer 2002; 38:64-69.
9. Ludovini V, Sidoni A, Pistola L, et al. Evaluation of the prognostic role of vascular endothelial growth factor and microvessèl density in stages I and II breast cancer patients. Breast Cancer Res Treat 2003; 81:159-168.
10. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
11. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 2005; 14:425-431.
12. Tsutsui S, Inoue H, Yasuda K, et al. Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density. Breast Cancer Res Treat 2006; 98:261-266.
13. Foster FS, Burns PN, Simpson DH, Wilson SR, Christopher DA, Goertz DE. Ultrasound for the visualization and quantification of tumor microcirculation. Cancer Metastasis Rev 2000; 19:131-138.
14. Klauser A, Demharter J, De Marchi A, et al. Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group. Eur Radiol 2005; 15:2404-2410.
15. Metz S, Daldrup-Unk HE, Richter T, et al. Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent Gadophrin-3. Acad Radiol 2003; 10:484-490.
16. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995; 26: 86-91.
17. Lichtenbeld HC, Barendsz-Janson AF, van Essen H, Struijker Boudier H, Griffioen AW, Hillen HF. Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model. Int J Cancer 1998; 77:455-459.
18. Bolat F, Kayaselcuk F, Nursal TZ, Yagmurdur MC, Bal N, Demirhan B. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J Exp Clin Cancer Res 2006; 25:365-372.
19. Valković T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjić N. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 2002; 440: 583-588.
20. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 1995; 197:33-38.
21. Oshida K, Nagashima T, Ueda T, et al. Pharmácokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. Eur Radiol 2005; 15:1353-1360.
22. Tuncbilek N, Unlu E, Karakas HM, Cakir B, Ozyilmaz F. Evaluation of tumor angiogenesis with contrast-enhanced dynamic magnetic resonance mammography. Breast J 2003; 9:403-408.
23. Su MY, Cheung YC, Fruehauf JP, et al. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging 2003; 18:467-477.
24. Stamper PC, Winston JS, Herman S, Klippenstein DL, Arredondo MA, Blumenson LE. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 1997; 45: 39-46.